Related Experiment Video
Updated: Jun 15, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Myocardial Recovery in Cardiogenic Shock
Kevin John1, Adnan Khalif2, Masaki Tsukashita2
1Tufts Medical Center, Boston, Massachusetts, US.
Insights
Improving cardiogenic shock (CS) outcomes focuses on preventing early death and promoting heart recovery. This review examines CS pathophysiology, recovery predictors, and knowledge gaps to enhance long-term survival strategies.
Area of Science:
- Cardiology
- Critical Care Medicine
- Pathophysiology
Background:
- Cardiogenic shock (CS) presents significant challenges to long-term patient survival.
- Current therapeutic strategies aim to reduce in-hospital mortality and prevent multiorgan failure.
- Heart replacement therapies offer long-term survival but are limited to a select patient group.
Purpose of the Study:
- To review the pathophysiology of the cardiogenic shock state.
- To identify strategies for optimizing physiological factors to promote myocardial recovery.
- To highlight current knowledge gaps and advocate for further research in CS myocardial recovery.
Main Methods:
- Literature review focusing on cardiogenic shock pathophysiology.
- Analysis of mechanisms to improve outcomes and promote heart recovery.
- Examination of therapeutic targets and predictors of myocardial recovery.
Main Results:
- Emphasis on addressing reversible etiologies contributing to the shock state.
- Identification of key physiological factors critical for recovery.
- Review of known predictors of myocardial recovery across various CS etiologies.
Conclusions:
- Optimizing recovery from cardiogenic shock is crucial for long-term survival.
- Further high-quality studies are needed to address knowledge gaps in myocardial recovery.
- Targeting reversible causes and promoting recovery are key therapeutic goals.
Abstract:
The overarching goal of cardiogenic shock (CS) therapy is ensuring long-term survival. In recent years, increasing emphasis has been placed on analyzing mechanisms to improve outcomes in CS. This includes averting in-hospital mortality, modifying the disease process by promoting heart recovery while avoiding multiorgan failure, and circumventing complications related to both CS and treatment strategies deployed to treat CS. Heart replacement therapies represent a viable strategy for long-term survival but are restricted to a small, select percentage of patients. In this review we focus on pathophysiology of the shock state, with an emphasis on addressing reversible etiologies contributing to the decompensated state, optimizing physiological factors for recovery, and identifying therapeutic targets to promote recovery. We also review the known predictors of myocardial recovery, regardless of the etiology of CS. Lastly, we highlight the current gaps in knowledge in this field and support additional high-quality studies focusing on myocardial recovery in CS.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021